Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors

NCT06233942 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

308

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: BG-C9074
DRUG: Tislelizumab
DRUG: Bevacizumab

Sponsor

BeOne Medicines